KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Average: 2009-2024

Historic Equity Average for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $1.1 billion.

  • Chemed's Equity Average fell 687.19% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 687.19%. This contributed to the annual value of $1.1 billion for FY2024, which is 1679.85% up from last year.
  • Latest data reveals that Chemed reported Equity Average of $1.1 billion as of FY2024, which was up 1679.85% from $953.3 million recorded in FY2023.
  • In the past 5 years, Chemed's Equity Average registered a high of $1.1 billion during FY2024, and its lowest value of $711.0 million during FY2022.
  • Its 5-year average for Equity Average is $870.8 million, with a median of $813.9 million in 2020.
  • Per our database at Business Quant, Chemed's Equity Average tumbled by 672.27% in 2022 and then soared by 3407.93% in 2023.
  • Chemed's Equity Average (Annual) stood at $813.9 million in 2020, then fell by 6.35% to $762.2 million in 2021, then decreased by 6.72% to $711.0 million in 2022, then skyrocketed by 34.08% to $953.3 million in 2023, then increased by 16.8% to $1.1 billion in 2024.
  • Its last three reported values are $1.1 billion in FY2024, $953.3 million for FY2023, and $711.0 million during FY2022.